Vynleads (VYND) Liabilities and Shareholders Equity (2020 - 2025)
Vynleads (VYND) reported Liabilities and Shareholders Equity of $53709.0 for Q4 2025, down 38.41% year-over-year from $87203.0 in Q4 2024, and up 31.79% on a QoQ basis from $40753.0 in Q3 2025.
Vynleads (VYND) has 6 years of Liabilities and Shareholders Equity data on file, last reported at $53709.0 in Q4 2025.
- Quarterly Liabilities and Shareholders Equity fell 38.41% year-over-year to $53709.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $150236.0 (up 6.13% YoY) and the FY2025 annual result came in at $53709.0, down 38.41% from the prior year.
- Liabilities and Shareholders Equity grew to $53709.0 in Q4 2025 per VYND's latest filing, from $40753.0 in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $87203.0 in Q4 2024 and bottomed at $14780.0 in Q3 2024.
- The 5-year median for Liabilities and Shareholders Equity is $24433.5 (2021), against an average of $29993.6.
- The widest annual swing landed in 2023, when Liabilities and Shareholders Equity slumped 54.76%; it then surged 175.73% in 2025.
- Tracing VYND's Liabilities and Shareholders Equity over 5 years: stood at $25390.0 in 2021, then dropped by 4.18% to $24328.0 in 2022, then surged by 49.64% to $36405.0 in 2023, then soared by 139.54% to $87203.0 in 2024, then tumbled by 38.41% to $53709.0 in 2025.
- Per Business Quant, the three latest VYND Liabilities and Shareholders Equity figures stand at $53709.0 (Q4 2025), $40753.0 (Q3 2025), and $16220.0 (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | 8.98 Bn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | 6.21 Bn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | 3.31 Bn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | 728.77 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | 1.12 Bn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | 5.84 Bn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | 1.02 Bn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | 1.42 Bn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | 2.00 Bn |
| 10 | Vynleads | - | - | -2,028.00 | 53,709.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 53,709.00 |
| Sep 30, 2025 | 40,753.00 |
| Jun 30, 2025 | 16,220.00 |
| Mar 31, 2025 | 39,554.00 |
| Dec 31, 2024 | 87,203.00 |
| Sep 30, 2024 | 14,780.00 |
| Jun 30, 2024 | 20,126.00 |
| Mar 31, 2024 | 19,448.00 |
| Dec 31, 2023 | 36,405.00 |
| Sep 30, 2023 | 15,846.00 |
| Jun 30, 2023 | 16,648.00 |
| Mar 31, 2023 | 39,271.00 |
| Dec 31, 2022 | 24,328.00 |
| Sep 30, 2022 | 24,735.00 |
| Jun 30, 2022 | 36,802.00 |
| Mar 31, 2022 | 20,544.00 |
| Dec 31, 2021 | 25,390.00 |
| Sep 30, 2021 | 21,851.00 |
| Jun 30, 2021 | 24,539.00 |
| Mar 31, 2021 | 21,719.00 |
| Dec 31, 2020 | 37,999.00 |